首页> 外文期刊>Brain & Development >Novel biallelic FA2H mutations in a Japanese boy with fatty acid hydroxylase-associated neurodegeneration
【24h】

Novel biallelic FA2H mutations in a Japanese boy with fatty acid hydroxylase-associated neurodegeneration

机译:日本男孩的新型双胞胎FA2H突变,脂肪酸羟化酶相关神经变性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

FA2H encodes fatty acid 2-hydroxylase, which plays a significant role in maintaining the neuronal myelin sheath. Previous reports have revealed that a FA2H mutation leads to spastic paraplegia, leukodystrophy, and neurodegeneration with brain iron accumulation, collectively referred to as fatty acid hydroxylase-associated neurodegeneration (FAHN). The disease severity of FAHN varies among individual patients and may be explained by the enzyme activity of FA2H mutant proteins. Here we report a 10-year-old Japanese boy with FAHN having novel heterozygous mutations in FA2H. The patient presented with a spastic gait since the age of 5 years and was unable to walk without a cane by the time he was 8 years old. Brain MRI demonstrated a partial thinning of the corpus callosum, slight reduction of cerebellar volume, and posterior dominant periventricular leukodystrophy. Whole exome sequencing revealed two novel missense mutations in FA2H with compound heterozygous inheritance (NM_024306, p.Val149Leu, and p.His260Gln mutations). The enzyme activities of the p.Val149Leu and p.His260Gln variants were 60%-80% and almost 0%, respectively. Our cell-based enzyme assay demonstrated partial functionality for one of the variants, indicating a milder phenotype. However, considered along with previous reports, there was no definite relationship between the disease severity and residual enzyme activity measured using a similar method. Further research is needed to precisely predict the phenotypic severity of this disorder. (C) 2019 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
机译:Fa2H编码脂肪酸2-羟基化酶,在维持神经元髓鞘中起着重要作用。以前的报道显示,FA2H突变导致痉挛性截瘫,白细胞萎缩和脑铁积累的神经变性,统称为脂肪酸羟化酶相关神经变性(FAHN)。 FAHN的疾病严重程度在个体患者中变化,并且可以通过FA2H突变蛋白的酶活性来解释。在这里,我们举报了一个10岁的日本男孩,Fahn在Fa2H中有新的杂合酶突变。自从5年的年龄以来,患者展示了痉挛性步态,并且在他8岁的时候,他无法在没有拐杖的情况下行走。脑MRI证明了语料库胼um的部分变薄,小脑体积的轻微减少,以及后冠状脑室的菌卵体。整体exome测序揭示了Fa2H中的两种新的麦基义突变,具有化合物杂合遗传(NM_024306,P.VAL149LE和P.HIS260GLN突变)。 P.Val149Leu和P.His260GLN变体的酶活性分别为60%-80%和近0%。我们的细胞基酶测定表明了一种变体的部分官能团,表明较高的表型。然而,考虑到以前的报告,疾病严重程度与使用类似方法测量的残留酶活性之间没有明确的关系。需要进一步研究来精确预测这种疾病的表型严重程度。 (c)2019年日本儿童神经病学会。 elsevier b.v出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号